Evaluating Drug-Target Complexes in Therapeutic Monoclonal Antibodies Using A4F-MALS: Implications for Drug Development and Clinical Design.
Saved in:
| Title: | Evaluating Drug-Target Complexes in Therapeutic Monoclonal Antibodies Using A4F-MALS: Implications for Drug Development and Clinical Design. |
|---|---|
| Authors: | Liu N; Product Biochemistry, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA, regeneron.com., Kotowski D; Product Biochemistry, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA, regeneron.com.; Analytical Research and Development, Merck and Co., Inc., Rahway, New Jersey, USA., Ong ET; Product Biochemistry, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA, regeneron.com., Devalaraja-Narashimha KB; Cardiovascular and Renal Research, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA, regeneron.com., Rosconi MP; Product Biochemistry, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA, regeneron.com., Pyles EA; Product Biochemistry, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA, regeneron.com. |
| Source: | Journal of immunology research [J Immunol Res] 2026; Vol. 2026 (1), pp. e8063033. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: Egypt NLM ID: 101627166 Publication Model: Print Cited Medium: Internet ISSN: 2314-7156 (Electronic) Linking ISSN: 23147156 NLM ISO Abbreviation: J Immunol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
